SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,085,000 | +3.6% | 218,625 | -20.7% | 0.96% | -3.2% |
| Q1 2018 | $12,626,000 | +4.2% | 275,675 | -9.3% | 1.00% | +12.3% |
| Q4 2017 | $12,114,000 | -7.9% | 303,995 | -7.6% | 0.89% | 0.0% |
| Q3 2017 | $13,158,000 | -23.6% | 328,945 | -17.7% | 0.89% | -13.0% |
| Q2 2017 | $17,220,000 | +7727.3% | 399,540 | +4389.2% | 1.02% | +9181.8% |
| Q3 2016 | $220,000 | -42.3% | 8,900 | -52.4% | 0.01% | -42.1% |
| Q2 2016 | $381,000 | -10.8% | 18,700 | -33.2% | 0.02% | -5.0% |
| Q1 2016 | $427,000 | -90.4% | 28,000 | -91.5% | 0.02% | -89.2% |
| Q4 2015 | $4,440,000 | -9.5% | 330,380 | -5.5% | 0.18% | -8.0% |
| Q3 2015 | $4,904,000 | -36.9% | 349,510 | -23.7% | 0.20% | -29.0% |
| Q2 2015 | $7,776,000 | – | 457,970 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |